| Autor: |
Matarese LE; Department of General Surgery, The Cleveland Clinic Foundation, Ohio 44195, USA., Speerhas R, Seidner DL, Steiger E |
| Jazyk: |
angličtina |
| Zdroj: |
JPEN. Journal of parenteral and enteral nutrition [JPEN J Parenter Enteral Nutr] 2000 May-Jun; Vol. 24 (3), pp. 170-3. |
| DOI: |
10.1177/0148607100024003170 |
| Abstrakt: |
Cytomegalovirus (CMV) is a serious complication of immunosuppressed patients receiving bone marrow transplantation. Foscarnet, a pyrophosphate analog, has been used in the treatment of CMV infections. Renal impairment and electrolyte abnormalities are potential adverse reactions associated with the use of foscarnet. We report a case of significant electrolyte changes after initiation of foscarnet in a bone marrow transplant patient receiving parenteral nutrition. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Plný text